Mexico acknowledged outstanding bills and pledged pharma debt payments, even as labs cite arrears and delivery hurdles that have fueled supply concerns . . .
X
|
|
Mexico acknowledged outstanding bills and pledged pharma debt payments, even as labs cite arrears and delivery hurdles that have fueled supply concerns . . .
